Illumina's Q3 Revenues Jump 50 Percent on Strength of HiSeq

The firm said sales for both its sequencing and microarray products pushed revenues up for the quarter. It also launched a new version of the HiSeq platform for lower-throughput applications.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories